Article Text

other Versions

PDF
Vascular disease in a population-based cohort of individuals hospitalized with coeliac disease
  1. Jonas F Ludvigsson (jonasludvigsson{at}yahoo.com)
  1. Karolinska University Hospital/Institute, Sweden
    1. Ulf de Faire
    1. Karolinska University Hospital/Institute, Sweden
      1. Anders Ekbom
      1. Karolinska University Hospital/Institute, Sweden
        1. Scott M Montgomery
        1. Karolinska University Hospital/Institute, Sweden

          Abstract

          Objectives To evaluate the risk of cardiovascular disease in individuals with coeliac disease (CD).

          Design We used Swedish national hospital-based register data to identify 13,358 individuals who had received a diagnosis of CD (1964-2003) and 64,118 age- and sex-matched individuals without CD. We then used Cox regression to estimate the risk of vascular disease in subjects with CD. Analyses were restricted to individuals with a follow-up of >1 year and with no vascular disease prior to study entry.

          Results CD was associated with (Hazard ratios (HR); 95% CI HR): myocardial infarction (1.27; 1.09-1.48), angina pectoris (1.46; 1.25-1.70), heart failure (1.41; 1.22-1.62), brain haemorrhage (1.40; 1.05-1.88), and ischaemic stroke (1.35; 1.14-1.60). These risk estimates were similar when we restricted our analyses to adults in whom vascular disease had been listed as the main diagnosis. In post-hoc analyses, where reference individuals were restricted to inpatients, we found no association with CD of later vascular disease, except for a lower risk of heart failure (0.79; 0.68-0.92).

          Conclusions The positive association between CD and later vascular disease may be explained by ascertainment bias.

          • autoimmune
          • coeliac
          • cohort study
          • heart disease
          • stroke

          Statistics from Altmetric.com

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.